Tokyo, Japan

Masayuki Sakuma

This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Sumitomo Dainippon Pharma Co., Ltd., Sumitomo Pharma Co., Ltd.. Active years: 2022-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masayuki Sakuma. Retrieved from https://idiyas.com/inventor/masayuki-sakuma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Masayuki Sakuma: Innovator in Pharmaceutical Chemistry

Introduction

Masayuki Sakuma is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds with therapeutic potential.

Latest Patents

Sakuma holds a patent for an aliphatic acid amide derivative. This invention relates to a compound represented by a specific formula, which exhibits antagonist activity against serotonin 5-HT receptors. The compound can also exist as a pharmaceutically acceptable salt. The formula includes various components, such as nitrogen atoms and carbonyl groups, with specific structural characteristics.

Career Highlights

Throughout his career, Masayuki Sakuma has worked with prominent companies in the pharmaceutical industry, including Sumitomo Dainippon Pharma Co., Ltd. and Sumitomo Pharma Co., Ltd. His work has contributed to advancements in drug development and therapeutic applications.

Collaborations

Sakuma has collaborated with esteemed colleagues, including Yuki Fujii and Yoshinori Aihara. These partnerships have fostered innovation and progress in their shared field of expertise.

Conclusion

Masayuki Sakuma's contributions to pharmaceutical chemistry and his innovative patent demonstrate his commitment to advancing medical science. His work continues to impact the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…